SELECTIVE INHIBITION OF GLUCONEOGENIC ACTIVITY
- 专利权人:
- Roger Schilling;Stuart L. Schreiber;Partha Pratim Nag;DANA-FARBER CANCER INSTITUTE, INC.;THE SCRIPPS RESEARCH INSTITUTE
- 发明人:
- Pere PUIGSERVER,Kfir SHARABI,Theodore KAMENECKA,Patrick GRIFFIN,Stuart L. SCHREIBER,Roger SCHILLING,Partha P. NAG,Joshua A. BITTKER
- 申请号:
- US16496178
- 公开号:
- US20200317620A1
- 申请日:
- 2018.03.21
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要:
- The present invention provides compounds, pharmaceutical compositions and methods for treating and/or preventing a metabolic condition, such as diabetes.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- ІНГІБІТОРИ КОТРАНСПОРТЕРА НАТРІЙГЛЮКОЗИ 2 І ЇХ ЗАСТОСУВАННЯ[ИНГИБИТОРЫ КОТРАНСПОРТЕРА НАТРИЙГЛЮКОЗЫ 2 И ИХ ПРИМЕНЕНИЕ
- ИНГИБИТОРЫ КОТРАНСПОРТЕРА НАТРИЙ-ГЛЮКОЗЫ 2 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
- Pharmaceutical ingredients, including slow-absorbing insulin mixtures; containers; suspensions, including their composition and formulation; for the treatment or prevention of insulin deficiency-related diseases, such as diabetes; and a toolkit.
- Cyclic amide derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase; comprising the pharmaceutical Composition and the use thereof in the Prevention or treatment of diseases such as diabetes.
- PYRROLIDIN GPR40 MODULATORS FOR TREATMENT OF DISEASES SUCH AS DIABETES